Is COVID-19 causing a spike in addiction rates?
Addiction is hard, especially in tough world or life circumstances, but with support from near or far, you can make it through.
EPA acknowledges proven dangers of bee-killing pesticides but refuses to restrict them
Neonicotinoids have already been banned by the European Union, it is time they were banned here.
Shutdowns stopped 60 million Covid-19 infections in the U.S., new research finds
The two studies provide fresh evidence that the severe economic sacrifice the COVID-19 shutdowns caused were worth it to save many millions of lives.
Removing Artificial Ingredients Helped Turn Around Cereal Sales
General Mills is selling more Cheerios, Lucky Charms, and other products, reversing losses suffered last year.
This organic food company doesn’t discriminate against ex-offenders—It seeks them out
Lancaster Food Company searches for job applicants who need help getting back on their feet. So far, not one has quit.
Monsanto Cuts 16% of Work Force as Sales in Roundup Herbicide Fall 34%
Monsanto has been struggling for investor confidence following the announcement in March 2015 that the World Health Organisation’s cancer agency had declared the world’s most widely used weedkiller – glyphosate – a “probable human carcinogen”.
Combining Medicare for All and the Biden healthcare plan
If Biden is going to be nominated, then Bernie and his supporters need to work hard to get the platform improved and make sure that Biden commits to the changes required under the platform.
CBO’s Obamacare predictions: How accurate?
CBO did better than the White House would have you believe.
As COVID-19 cases spike, epidemiologist warns ‘the road to an uncertain vaccine is paved...
We speak with Dr. Ali Khan, epidemiologist and the dean of the College of Public Health at the University of Nebraska Medical Center, about the Trump administration’s handling of the crisis and his hopes for a vaccine.
Life-Saving Allergy Treatment Is Becoming Too Expensive For Families To Afford
Over the past nine years, since Mylan bought the rights to the EpiPen, the price for the easy-to-use injectors has quintupled — increasing about 450 percent, from around $50 for one injector to $600 for a pack of two.